全球 DNA 奈米技术市场按类型、应用、最终用户和地区划分

预计 2025 年全球 DNA 奈米技术市场规模为 44 亿美元，到 2032 年将达到 212.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 25.2%。

数字。 2025年全球市场占有率（%）

DNA奈米技术是一个新兴领域，它利用DNA的独特特性来设计新的DNA序列并在奈米级上操纵材料。透过利用 DNA 碱基对的高度特异性结合特性，DNA 奈米技术使科学家能够利用 DNA 和其他材料来建构动态设备和结构。 DNA奈米技术有望应用于医疗保健、电子和材料等多个产业。 DNA奈米技术透过DNA和其他核酸的分子识别和自组织能力，实现了可程式设计和可寻址的奈米级结构、设备和系统的开发。 DNA摺纸技术的进步现在允许研究人员将长单链DNA折迭成奈米级预先定义的二维和三维形状。 DNA奈米技术的持续进步将彻底改变药物传输、合成生物学和奈米电子学等领域。

市场动态：

市场驱动因素包括对基于奈米技术的诊断技术的日益关注、对靶向药物输送方法开发的投资不断增加以及 DNA 奈米技术在各种应用中的日益普及，这些因素正在推动 DNA 奈米技术市场的成长。然而，DNA奈米技术研究的高成本和DNA摺纸製造的技术限制预计会抑制市场成长。同时，DNA奈米技术在材料科学的应用，开发具有独特性能的功能性材料，也蕴藏新的商机。自动化 DNA 摺纸设计、建模和製造方面的进步也有望帮助解决现有的挑战，并在未来几年进一步推动市场成长。

DNA奈米技术利用DNA和其他核酸的分子辨识特性在奈米级上创建复杂的可程式设计结构。 DNA奈米技术可用于开发灵敏的生物感测器，以检测与各种疾病相关的生物标记物，从而提高诊断能力。 DNA奈米结构可以设计成以受控的方式携带和释放药物分子，使它们能够靶向特定的细胞和组织。基于DNA的奈米结构可以作为精确的成像剂，提高成像技术的分辨率和特异性。除了药物传递之外，DNA奈米技术还可以实现基因调控疗法以及建构能够与生物系统相互作用以达到治疗目的的奈米级设备。 DNA 有可能透过提供高密度资料储存介质和生物运算系统的开发来彻底改变计算方式。 DNA奈米技术正被用于创造具有可编程功能和特性的新材料，影响从电子到生物技术等各个行业。

例如，2024年9月，研究机构文理学院的RNA研究所从美国美国卫生研究院下属的国家普通医学科学研究所接受190万美元资助，用于支持探索如何将DNA奈米技术用于生物医学和材料科学应用的研究。

本研究的主要特点

• 本研究报告对全球 DNA 奈米技术市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球 DNA 奈米技术市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球 DNA 奈米技术市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球 DNA 奈米技术市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 基因组学和蛋白​​质组学研究进展
• 材料科学与工程进展
• 医疗产业的兴趣日益浓厚
• 奈米技术领域的成长
• 限制因素
• 市场机会
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

第四章 冠状病毒（COVID-19）疫情的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球 DNA 奈米技术市场（按类型）

• 结构DNA奈米技术
• 扩充格子
• 离散结构
• 组装模板
• 动态 DNA 奈米技术
• 奈米机械设备
• 链置换连锁

6. 全球DNA奈米技术市场（按应用划分），2020-2032年

• 靶向药物输送
• 智慧药丸
• 奈米光刻
• 其他的

7. 全球 DNA 奈米技术市场（按最终用户划分），2020 年至 2032 年

• 生物技术和製药公司
• 学术研究所
• 其他的

8. 2020 年至 2032 年全球 DNA 奈米技术市场（按地区）

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第九章 竞争态势

• NuProbe
• GATTAQUANT GMBH
• Genisphere LLC
• INOVIO Pharmaceuticals.
• tilibit nanosystems
• Aummune Therapeutics Ltd.
• Nanovery
• Esya Labs
• Nomic
• Torus Biosystems
• Parabon NanoLabs, Inc.
• NanoApps Medical Inc.
• FOx BIOSYSTEMS
• Nanion Technologies GmbH
• Mehr Mabna Darou, Inc.
• Nanowerk

第 10 章 章节

• 调查方法
• 关于出版商

Global DNA Nanotechnology Market is estimated to be valued at USD 4.4 Bn in 2025 and is expected to reach USD 21.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.2% from 2025 to 2032.

Figure. Global DNA Nanotechnology Market Share (%), By Region 2025

DNA nanotechnology is an emerging field that utilizes the unique properties of DNA to engineer novel arrangements of DNA, and manipulate materials at the nanoscale level. By exploiting the highly specific binding properties of DNA base pairs, DNA nanotechnology allows scientists to construct dynamic devices and structures from DNA and other materials. DNA nanotechnology holds significant promise for applications across various industries, including healthcare, electronics, and materials. It enables the development of programmable and addressable nanoscale structures, devices, and systems through the molecular recognition and self-assembly capabilities of DNA and other nucleic acids. Advances in DNA origami techniques now allow researchers to fold long single strands of DNA into predefined two-dimensional and three-dimensional shapes at the nanoscale. Continued progress in DNA nanotechnology is poised to revolutionize fields such as drug delivery, synthetic biology, nanoelectronics, and more.

Market Dynamics:

Drivers such as the growing focus on nanotechnology-based diagnostic techniques, rising investments in the development of targeted drug delivery methods, and increasing adoption of DNA nanotechnology for various applications are fueling the growth of the DNA nanotechnology market. However, high costs associated with DNA nanotechnology research and technical limitations related to DNA origami fabrication are expected to restrain the market growth. Meanwhile, emerging opportunities lie in the application of DNA nanotechnology in material science for developing functional materials with unique properties. Advances in automated DNA origami design, modeling, and fabrication also hold promise to help address existing challenges and further stimulate market growth in the coming years.

DNA nanotechnology utilizes the molecular recognition properties of DNA and other nucleic acids to create complex, programmable structures at the nanoscale. DNA nanotechnology can be used to develop highly sensitive biosensors for the detection of biomarkers associated with various diseases, improving diagnostic capabilities. DNA nanostructures can be designed to carry and release drug molecules in a controlled manner, targeting specific cells or tissues, which has implications for cancer therapy, among other diseases. DNA-based nanostructures can serve as precise imaging agents, enhancing the resolution and specificity of imaging techniques. Beyond drug delivery, DNA nanotechnology may enable gene regulation therapies and the construction of nano-scale devices that can interact with biological systems for therapeutic purposes. DNA has the potential to revolutionize computing by providing a medium for high-density data storage and the development of biological computing systems. DNA nanotechnology is being used to create novel materials with programmable functions and properties, impacting industries from electronics to biotechnology

For instance, in September 2024, RNA Institute in the College of Arts and Sciences, a research institute, received US$1.9 million from the National Institute of General Medical Sciences, a branch of the National Institutes of Health, to support research exploring ways to exploit DNA nanotechnology for biomedical and materials science applications.

Key features of the study:

• This report provides in-depth analysis of the global DNA nanotechnology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global DNA nanotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include NuProbe, GATTAQUANT GMBH, Genisphere LLC, INOVIO Pharmaceuticals., tilibit nanosystems, Aummune Therapeutics Ltd., Nanovery, Esya Labs, Nomic, Torus Biosystems, Parabon NanoLabs, Inc., NanoApps Medical Inc., FOx BIOSYSTEMS, Nanion Technologies GmbH, Mehr Mabna Darou, Inc., Nanowerk
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global DNA nanotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA nanotechnology market

Detailed Segmentation:

• By Type:
  • Structural DNA Nanotechnology
  • Extended Lattices
  • Discrete Structures
  • Template Assembly
  • Dynamic DNA Nanotechnology
  • Nanomechanical Devices
  • Strand Displacement Cascades
• By Application:
  • Targeted Drug Delivery
  • Smart Pills
  • Nanolithography
  • Others
• By End User:
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • GATTAQUANT GMBH
  • Genisphere LLC
  • INOVIO Pharmaceuticals.
  • tilibit nanosystems
  • Aummune Therapeutics Ltd.
  • Nanovery
  • Esya Labs
  • Nomic
  • Torus Biosystems
  • Parabon NanoLabs, Inc.
  • NanoApps Medical Inc.
  • FOx BIOSYSTEMS
  • Nanion Technologies GmbH
  • Mehr Mabna Darou, Inc.
  • Nanowerk

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • DNA Nanotechnology Market, By Type
  • DNA Nanotechnology Market, By Application
  • DNA Nanotechnology Market, By End User
  • DNA Nanotechnology Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
• Advancing genomics and proteomics research
• Advancements in material science and engineering
• Growing interest from the medical industry
• Growth in the field of nanotechnology
• Restraints
• Market Opportunity
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global DNA Nanotechnology Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Structural DNA Nanotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Extended Lattices
• Discrete Structures
• Template Assembly
• Dynamic DNA Nanotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nanomechanical Devices
• Strand Displacement Cascades

6. Global DNA Nanotechnology Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Targeted Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Smart Pills
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nanolithography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global DNA Nanotechnology Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Biotechnology & Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Academic & Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global DNA Nanotechnology Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• NuProbe
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GATTAQUANT GMBH
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genisphere LLC
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• INOVIO Pharmaceuticals.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• tilibit nanosystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Aummune Therapeutics Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nanovery
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Esya Labs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nomic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Torus Biosystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Parabon NanoLabs, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NanoApps Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FOx BIOSYSTEMS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nanion Technologies GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mehr Mabna Darou, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nanowerk
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us